Toru Yoshimitsu
Director/Board Member en OCATA THERAPEUTICS INC .
Perfil
Toru Yoshimitsu is currently a Director at Astellas Institute for Regenerative Medicine.
Previously, he worked as a Director at Astellas Pharma Europe Ltd.
from 2017 to 2020 and as a Director at Astellas Gene Therapies, Inc.
Cargos activos de Toru Yoshimitsu
Empresas | Cargo | Inicio |
---|---|---|
OCATA THERAPEUTICS INC | Director/Board Member | - |
Antiguos cargos conocidos de Toru Yoshimitsu.
Empresas | Cargo | Fin |
---|---|---|
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Director/Board Member | 31/03/2020 |
AUDENTES THERAPEUTICS, INC. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Astellas Institute for Regenerative Medicine
Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Toru Yoshimitsu